ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.023 AUD 4.55% Market Closed
Market Cap: AU$46.9m

ImpediMed Ltd
Goodwill

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

ImpediMed Ltd
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Goodwill CAGR 3Y CAGR 5Y CAGR 10Y
ImpediMed Ltd
ASX:IPD
Goodwill
AU$2.8m
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
2%
Somnomed Ltd
ASX:SOM
Goodwill
AU$7m
CAGR 3-Years
5%
CAGR 5-Years
2%
CAGR 10-Years
N/A
C
Cyclopharm Ltd
ASX:CYC
Goodwill
AU$996.2k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cochlear Ltd
ASX:COH
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Austco Healthcare Ltd
ASX:AHC
Goodwill
AU$21.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
EMvision Medical Devices Ltd
ASX:EMV
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

ImpediMed Ltd
Glance View

Market Cap
46.9m AUD
Industry
Health Care

ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. The company is headquartered in Brisbane, Queensland and currently employs 73 full-time employees. The company went IPO on 2007-10-24. The firm develops various medical products that use bioimpedance spectroscopy (BIS) to measure and monitor fluid status and tissue composition. Its product includes SOZO Digital Health Platform. The company is a non-invasive BIS device delivers a snapshot of fluid status and tissue composition in approximately 30 seconds. The Company’s SOZO Applications offer clinicians deeper insights into a patient’s health. SOZO Applications include various software applications, such as L-Dex Analysis for Lymphedema, Body Composition Analysis, Segmental Analysis and HF-Dex Analysis for Heart Failure. The Company’s research devices include SFB7 and ImpediVET. SFB7 single channel, tetrapolar BIS device, which measures fluid status and tissue composition for clinical and research applications.

IPD Intrinsic Value
HIDDEN
Show

See Also

What is ImpediMed Ltd's Goodwill?
Goodwill
2.8m AUD

Based on the financial report for Jun 30, 2025, ImpediMed Ltd's Goodwill amounts to 2.8m AUD.

What is ImpediMed Ltd's Goodwill growth rate?
Goodwill CAGR 10Y
2%

Over the last year, the Goodwill growth was 2%. The average annual Goodwill growth rates for ImpediMed Ltd have been 2% over the past three years , 1% over the past five years , and 2% over the past ten years .

Back to Top